Medicham 100/182
Raw Prices
As an eBay Partner Network affiliate, Card Codex earns from qualifying purchases. Learn more
Price History (Raw)
PSA Graded Prices
As an eBay Partner Network affiliate, Card Codex earns from qualifying purchases. Learn more
Population Report (PSA)
How often each PSA grade appears in the population for this card variant.
- PSA 10 Gem Mint00.00%—
- PSA 9 Mint2100.00%$19.95
- PSA 8 Near Mint-Mint00.00%—
- PSA 7 Near Mint00.00%—
- PSA 6 Excellent-Mint00.00%—
- PSA 5 Excellent00.00%—
- PSA 4 Very Good-Excellent00.00%—
- PSA 3 Very Good00.00%—
- PSA 2 Good00.00%—
- PSA 1 Poor00.00%—
Is Medicham 100/182 worth grading?
Net profit at each grade — after grading, fees & tax on a $0.12 raw copy.
- Profit
- Loss
- Break-even
Based on $28 grading + shipping and 13% marketplace fees & tax on a $0.12 raw cost.
Keep in mind: Don't forget about PSA upcharges! High-value cards that get top grades are often bumped to higher pricing tiers by PSA, which can alter your final profit margins.
About Medicham
Through yoga training, it gained the psychic power to predict its foe's next move.
Card Details
- Card TypePokémon
- Featured Pokémon
- National Pokédex #[308]
- Card Number 100/182
- Card RarityUncommon
- IllustratorWhisker
- Release Date30/05/2025
- Regulation MarkI
- SeriesScarlet & Violet
- Expansion Destined Rivals
- Evolves From
- Standard FormatLegal
- Expanded FormatLegal
- Unlimited FormatLegal
- EraModern
- Production StatusIn Print
- RegionHoenn
- Generation Generation 3
Card Attributes
- Energy Type
Fighting - Health Points120 HP
- Weakness
Psychic ×2 - Retreat Cost
Colorless ×1
Attacks
- Harmonious Spirit Palm50+

If this Pokémon and your opponent's Active Pokémon have the same amount of Energy attached, this attack does 120 more damage.
Artwork Description
Playability Overview
Binder Inspiration
User Comments
Discuss pulls, prices and grading for Medicham · Destined Rivals with the Card Codex community.
0 comments
No comments yet. Be the first to start the discussion about Medicham · Destined Rivals.
















